LDL Elevation in Menopause - Interpreting Lipids in Primary Care

LDL Elevation in Menopause- Interpreting Lipids in Primary Care

Written byLauren Wallis Dyer- BSc (Hons) Nutritional Biochemistry | MSc Medical Molecular Biology DipCLN | FNTP | IFM Certified Health Coach Clinical Functional Nutrition Practitioner Lauren Wallis Nutrition | Bedfordshire | UK & International Clients

LDL cholesterol often rises during the menopausal transition. This is well described in the literature and occurs independently of age. It reflects changes in oestrogen signalling.

Oestrogen has a direct effect on lipid metabolism. It influences LDL receptor activity in the liver, cholesterol clearance and bile production. As oestrogen levels fall, LDL receptor activity reduces and circulating LDL increases. This is a predictable physiological response and is seen consistently across different populations.

When HRT is started, lipid levels can become unstable in the early phase. The liver is adjusting to a new hormonal signal and that process is not immediate. It is not unusual to see LDL rise or fluctuate during the first few months.

The route of administration also plays a role. Oral oestrogen passes through the liver and can alter lipid handling differently to transdermal preparations. Transdermal oestrogen tends to produce a more stable response. The addition of progesterone or testosterone can also influence lipid levels.

LDL should not be interpreted in isolation. In clinical practice, many women in this phase present with low triglycerides and high HDL. This pattern is commonly seen alongside preserved insulin sensitivity. LDL elevation can sit within this profile without other metabolic markers being raised.

Sleep and stress are highly relevant. Many menopausal women report disrupted sleep, early waking and vasomotor symptoms. Cortisol influences hepatic cholesterol production and can raise LDL. Lipid changes are often seen alongside poor sleep and increased sympathetic activation.

Physical activity also needs to be considered carefully. Reduced activity can affect lipid handling. At the same time, a number of women experience impaired recovery and reduced tolerance to exercise during this phase. Higher intensity exercise can aggravate symptoms and may not improve lipid markers.

Interpretation of LDL should sit alongside other markers, including HbA1c, CRP and fasting glucose, as well as an understanding of the individual’s symptoms and lifestyle. Where available, ApoB or particle number can provide additional insight into cardiovascular risk.

From a nutritional perspective, changes in LDL at this stage are not usually driven by dietary fat intake alone. Blanket recommendations to reduce fat or increase fibre do not reflect the underlying physiology. A more useful approach is to support overall metabolic stability, including adequate protein intake, regular meals and avoidance of significant under-fuelling, particularly in physically active individuals.

Very low carbohydrate diets require a shift in fuel utilisation away from glucose towards fat. This is accompanied by lower insulin levels, increased lipolysis and greater reliance on circulating lipoproteins to transport fatty acids. In this state, LDL can rise as part of normal lipid trafficking rather than as a marker of impaired metabolism. This is more commonly seen in individuals with low triglycerides and high HDL, where insulin sensitivity is preserved.

In menopausal women, this effect can be more pronounced. Reduced oestrogen influences hepatic LDL receptor activity and cholesterol clearance. When combined with increased lipid mobilisation from very low carbohydrate intake, circulating LDL levels may increase further. This can occur in the absence of other adverse metabolic markers.

Very low carbohydrate intake can also influence cortisol and sleep in some individuals. Lower glycogen availability and increased reliance on gluconeogenesis can contribute to early waking and reduced exercise recovery. Where sleep is already disrupted, this can reinforce the physiological drivers associated with changes in lipid handling.

In practice, dietary patterns that support stable energy availability, recovery and hormonal regulation tend to be more relevant than targeting LDL directly.

LDL elevation during menopause and early HRT is common. These changes are frequently observed alongside hormonal transition, altered sleep and changes in stress physiology. Interpretation requires consideration of the wider clinical picture.

Read more of Lauren’s work

Medicine Central is a clinical evidence review for UK primary care clinicians. Content reflects evidence current at time of publication and should be read alongside local formulary and clinical guidance. Guest contributors retain responsibility for the accuracy and originality of their work. Views expressed are the author's own and do not necessarily reflect those of Medicine Central. For healthcare professionals only.